FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2528569315> ?p ?o ?g. }

• W2528569315 endingPage "12" @default.
• W2528569315 startingPage "4" @default.
• W2528569315 abstract "Rationale and Objectives Evidence-based treatment and management for patients with bronchiectasis remain challenging. There is a need for regional disease measurements as focal distribution of disease is common. Our objective was to evaluate the ability of magnetic resonance imaging (MRI) to detect regional ventilation impairment and response to airway clearance therapy (ACT) in patients with noncystic fibrosis (CF) bronchiectasis, providing a new way to objectively and regionally evaluate response to therapy. Materials and Methods Fifteen participants with non-CF bronchiectasis and 15 age-matched healthy volunteers provided written informed consent to an ethics board-approved Health Insurance Portability and Accountability Act-compliant protocol and underwent spirometry, plethysmography, computed tomography (CT), and hyperpolarized 3He MRI. Bronchiectasis patients also completed a Six-Minute Walk Test, the St. George's Respiratory questionnaire, and Patient Evaluation Questionnaire (PEQ), and returned for a follow-up visit after 3 weeks of daily oscillatory positive expiratory pressure use. CT evidence of bronchiectasis was qualitatively reported by lobe, and MRI ventilation defect percent (VDP) was measured for the entire lung and individual lobes. Results CT evidence of bronchiectasis and abnormal VDP (14 ± 7%) was observed for all bronchiectasis patients and no healthy volunteers. There was CT evidence of bronchiectasis in all lobes for 3 patients and in 3 ± 1 lobes (range = 1–4) for 12 patients. VDP in lobes with CT evidence of bronchiectasis (19 ± 12%) was significantly higher than in lobes without CT evidence of bronchiectasis (8 ± 5%, P = .001). For patients, VDP in lung lobes with (P < .0001) and without CT evidence of bronchiectasis (P = .006) was higher than in healthy volunteers (3 ± 1%). For all patients, mean PEQ-ease-bringing-up-sputum (P = .048) and PEQ-patient-global-assessment (P = .01) were significantly improved post-oscillatory positive expiratory pressure. An improvement in regional VDP greater than the minimum clinical important difference was observed for 8 of the 14 patients evaluated. Conclusions There was CT and MRI evidence of structure-function abnormalities in patients with bronchiectasis; in approximately half, there was evidence of ventilation improvements after airway clearance therapy. Evidence-based treatment and management for patients with bronchiectasis remain challenging. There is a need for regional disease measurements as focal distribution of disease is common. Our objective was to evaluate the ability of magnetic resonance imaging (MRI) to detect regional ventilation impairment and response to airway clearance therapy (ACT) in patients with noncystic fibrosis (CF) bronchiectasis, providing a new way to objectively and regionally evaluate response to therapy. Fifteen participants with non-CF bronchiectasis and 15 age-matched healthy volunteers provided written informed consent to an ethics board-approved Health Insurance Portability and Accountability Act-compliant protocol and underwent spirometry, plethysmography, computed tomography (CT), and hyperpolarized 3He MRI. Bronchiectasis patients also completed a Six-Minute Walk Test, the St. George's Respiratory questionnaire, and Patient Evaluation Questionnaire (PEQ), and returned for a follow-up visit after 3 weeks of daily oscillatory positive expiratory pressure use. CT evidence of bronchiectasis was qualitatively reported by lobe, and MRI ventilation defect percent (VDP) was measured for the entire lung and individual lobes. CT evidence of bronchiectasis and abnormal VDP (14 ± 7%) was observed for all bronchiectasis patients and no healthy volunteers. There was CT evidence of bronchiectasis in all lobes for 3 patients and in 3 ± 1 lobes (range = 1–4) for 12 patients. VDP in lobes with CT evidence of bronchiectasis (19 ± 12%) was significantly higher than in lobes without CT evidence of bronchiectasis (8 ± 5%, P = .001). For patients, VDP in lung lobes with (P < .0001) and without CT evidence of bronchiectasis (P = .006) was higher than in healthy volunteers (3 ± 1%). For all patients, mean PEQ-ease-bringing-up-sputum (P = .048) and PEQ-patient-global-assessment (P = .01) were significantly improved post-oscillatory positive expiratory pressure. An improvement in regional VDP greater than the minimum clinical important difference was observed for 8 of the 14 patients evaluated. There was CT and MRI evidence of structure-function abnormalities in patients with bronchiectasis; in approximately half, there was evidence of ventilation improvements after airway clearance therapy." @default.
• W2528569315 created "2016-10-14" @default.
• W2528569315 creator A5015914747 @default.
• W2528569315 creator A5020583398 @default.
• W2528569315 creator A5062417502 @default.
• W2528569315 creator A5072668158 @default.
• W2528569315 date "2017-01-01" @default.
• W2528569315 modified "2023-09-25" @default.
• W2528569315 title "Noncystic Fibrosis Bronchiectasis" @default.
• W2528569315 cites W1584330193 @default.
• W2528569315 cites W1770155842 @default.
• W2528569315 cites W1894768163 @default.
• W2528569315 cites W1991463859 @default.
• W2528569315 cites W1995487477 @default.
• W2528569315 cites W1997384023 @default.
• W2528569315 cites W2027928218 @default.
• W2528569315 cites W2032302920 @default.
• W2528569315 cites W2040022821 @default.
• W2528569315 cites W2048571011 @default.
• W2528569315 cites W2052712024 @default.
• W2528569315 cites W2052977441 @default.
• W2528569315 cites W2059587208 @default.
• W2528569315 cites W2065327759 @default.
• W2528569315 cites W2071780061 @default.
• W2528569315 cites W2078237160 @default.
• W2528569315 cites W2078249623 @default.
• W2528569315 cites W2088828277 @default.
• W2528569315 cites W2097419280 @default.
• W2528569315 cites W2100799766 @default.
• W2528569315 cites W2104038900 @default.
• W2528569315 cites W2112433656 @default.
• W2528569315 cites W2113576511 @default.
• W2528569315 cites W2118118900 @default.
• W2528569315 cites W2125078269 @default.
• W2528569315 cites W2135658961 @default.
• W2528569315 cites W2156772274 @default.
• W2528569315 cites W2158830594 @default.
• W2528569315 cites W2167733034 @default.
• W2528569315 cites W2170309616 @default.
• W2528569315 cites W2291379829 @default.
• W2528569315 cites W4236741674 @default.
• W2528569315 cites W4248707093 @default.
• W2528569315 doi "https://doi.org/10.1016/j.acra.2016.08.021" @default.
• W2528569315 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27717759" @default.
• W2528569315 hasPublicationYear "2017" @default.
• W2528569315 type Work @default.
• W2528569315 sameAs 2528569315 @default.
• W2528569315 citedByCount "11" @default.
• W2528569315 countsByYear W25285693152017 @default.
• W2528569315 countsByYear W25285693152018 @default.
• W2528569315 countsByYear W25285693152019 @default.
• W2528569315 countsByYear W25285693152020 @default.
• W2528569315 countsByYear W25285693152021 @default.
• W2528569315 countsByYear W25285693152022 @default.
• W2528569315 crossrefType "journal-article" @default.
• W2528569315 hasAuthorship W2528569315A5015914747 @default.
• W2528569315 hasAuthorship W2528569315A5020583398 @default.
• W2528569315 hasAuthorship W2528569315A5062417502 @default.
• W2528569315 hasAuthorship W2528569315A5072668158 @default.
• W2528569315 hasConcept C126322002 @default.
• W2528569315 hasConcept C126838900 @default.
• W2528569315 hasConcept C143409427 @default.
• W2528569315 hasConcept C2776042228 @default.
• W2528569315 hasConcept C2777714996 @default.
• W2528569315 hasConcept C2779379686 @default.
• W2528569315 hasConcept C2780333948 @default.
• W2528569315 hasConcept C71924100 @default.
• W2528569315 hasConceptScore W2528569315C126322002 @default.
• W2528569315 hasConceptScore W2528569315C126838900 @default.
• W2528569315 hasConceptScore W2528569315C143409427 @default.
• W2528569315 hasConceptScore W2528569315C2776042228 @default.
• W2528569315 hasConceptScore W2528569315C2777714996 @default.
• W2528569315 hasConceptScore W2528569315C2779379686 @default.
• W2528569315 hasConceptScore W2528569315C2780333948 @default.
• W2528569315 hasConceptScore W2528569315C71924100 @default.
• W2528569315 hasFunder F4320334506 @default.
• W2528569315 hasIssue "1" @default.
• W2528569315 hasLocation W25285693151 @default.
• W2528569315 hasLocation W25285693152 @default.
• W2528569315 hasOpenAccess W2528569315 @default.
• W2528569315 hasPrimaryLocation W25285693151 @default.
• W2528569315 hasRelatedWork W1957770986 @default.
• W2528569315 hasRelatedWork W2000416421 @default.
• W2528569315 hasRelatedWork W2011612780 @default.
• W2528569315 hasRelatedWork W2035205383 @default.
• W2528569315 hasRelatedWork W2382578366 @default.
• W2528569315 hasRelatedWork W2462739481 @default.
• W2528569315 hasRelatedWork W2469072756 @default.
• W2528569315 hasRelatedWork W2912210870 @default.
• W2528569315 hasRelatedWork W3167643569 @default.
• W2528569315 hasRelatedWork W4322724676 @default.
• W2528569315 hasVolume "24" @default.
• W2528569315 isParatext "false" @default.
• W2528569315 isRetracted "false" @default.
• W2528569315 magId "2528569315" @default.
• W2528569315 workType "article" @default.